B. Braun

Last updated

B. Braun Melsungen SE
Company type Societas Europaea
Industry Healthcare
Founded1839;185 years ago (1839)
FounderJulius Wilhelm Braun
Headquarters Melsungen, Germany
Key people
Anna Maria Braun (CEO)
RevenueIncrease2.svg 8,755 million (2023) [1]
Number of employees
Decrease2.svg 63,011 (2023) [1]
Website www.bbraun.com
B. Braun offices in Prague. Praha Chodov V Parku 16 B Braun.jpg
B. Braun offices in Prague.
Dialog dialysis machine from B. Braun Dialog-dialysis-machine-b-braun.jpg
Dialog dialysis machine from B. Braun

B. Braun is a German medical and pharmaceutical device company, which currently has more than 63,000 employees globally, and offices and production facilities in more than 60 countries. Its headquarters are located in Melsungen, in central Germany. The company was founded in 1839 and is still owned by the Braun family. [2]

Contents

B. Braun has more than 5,000 different healthcare products, of which 95% are manufactured by the company. In 2018, the company had a revenue of 6.908 Billion Euros.

History

The company began in 1839 as a pharmacy in Melsungen, where it started to sell medical herbs by mail to customers in Germany.

Later, a manufacturing plant was built, where production of several medical products began, mainly surgical sutures. With this product, Braun started to supply to hospitals, and added in the following decades other product lines to its manufacturing program, like intravenous solutions, monitoring apparatus and other medical devices. In the 1960s Braun became highly specialised in plastics for pharmaceutical and medical uses, and developed the first plastic container for I. V. solutions in 1956, as well as many other products for patient care in hospitals.[ citation needed ]

As the company grew, manufacturing facilities were acquired or established in the United Kingdom, France, Italy, Spain, Switzerland, Hungary, Slovakia, Czech Republic, the United States, Brazil and Malaysia. B. Braun acquired Aesculap AG, a Germany-based manufacturer of surgical instruments. B. Braun and its subsidiaries employ more than 54,000 people in more than 60 countries as of 2014. [3]

In 1969, the company introduced Lyodura. Similar products from other manufacturers were removed from the market in the USA and Canada in 2002. [4] In the same year, B. Braun Melsungen agreed with the Japanese health authorities to pay compensation to the families of the victims of over $600,000 each. [4]

In 2009, the company was named the best company in Germany to work for. [5]

In February 2012, the company announced that it was no longer passing on human insulin. [6] In the same year, B. Braun came into the market for genetic diagnostics with a participation in Tübinger Cegat GmbH. [7]

From 2012 to 2013, B. Braun increased its share in Rhön-Klinikum from 5 to 18 percent in order secure a minority blocking stake in the company; [8] it also won antitrust approval for raising its stake to 25 percent. [9] Together with another shareholder, hospitals operator Asklepios Kliniken, it opposed a takeover by Fresenius. [10] In late 2013, B. Braun filed a lawsuit to contest the sale of most of Rhön-Klinikum’s hospitals, which accounted for about two-thirds of the company’s revenues. [11] After that sale was completed, B. Braun reduced its share. [12]

In 2013, B. Braun opened a day and seminar center in the Haydau monastery complex in Morschen. [13]

In 2017, B. Braun and Philips entered into an alliance in the field of ultrasound-guided regional anesthesia. [14] In 2018, B. Braun opened a new production facility for dialyzers in Wilsdruff, Saxony. [13]

Divisions

B.Braun Infusomat fmS Infusomat fmS Braun.JPG
B.Braun Infusomat fmS

On an international level, B. Braun is separated into several divisions: [15]

The United Kingdom headquarters are located in Chapeltown, just north of Sheffield in South Yorkshire. The United States headquarters are located in Bethlehem, Pennsylvania, where the subsidiary company is known as B. Braun Medical, Inc. [17] It sells pharmaceutical and medical products. [18]

Aesculap

B. Braun's Aesculap division, (/æsˈkliːp/), which includes Aesculap, Inc., its American unit, is a manufacturer of surgical equipment. It derives its name from Aesculapius, the Greek and Roman god of medicine and physicians. It manufactures a range of equipment including sutures, handheld surgical instruments, implants, and electrosurgical devices and powers systems. During the Second World War they produced tattoo stamps used in German extermination camps. They also provide training to healthcare workers through its Aesculap Academy. [19] [20]

Aesculap was founded in 1867 in Tuttlingen, Germany by Gottfried Jetter.

Aesculap, Inc., its American division, was founded in 1977 in Center Valley, Pennsylvania. Aesculap AG was incorporated into the B. Braun Group in 1998. [21]

In 2010, B. Braun Medical, a unit of B. Braun, agreed to pay $14.7 million for causing the Medicaid program in the US to pay inflated amounts on dozens of its products. [22]

Related Research Articles

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

<span class="mw-page-title-main">Roche</span> Swiss multinational healthcare company

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.

<span class="mw-page-title-main">McKesson Corporation</span> U.S. healthcare company

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. McKesson had revenues of $276 billion in its fiscal year ending March 31, 2023.

<span class="mw-page-title-main">Cardinal Health</span> American multinational health care services company

Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical products, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.

<span class="mw-page-title-main">Tuttlingen</span> Town in Baden-Württemberg, Germany

Tuttlingen is a town in Baden-Württemberg, capital of the district Tuttlingen. Nendingen, Möhringen and Eßlingen are three former municipalities that belong to Tuttlingen. Tuttlingen is located in Swabia east of the Black Forest region in the Swabian Jura.

<span class="mw-page-title-main">Linde plc</span> Largest global industrial gas producer

Linde plc is a global multinational chemical company founded in Germany and, since 2018, domiciled in Ireland and headquartered in the United Kingdom. Linde is the world's largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, material handling equipment (MHE), chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, ammonia, electronic gases, specialty gases, and acetylene.

Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.

<span class="mw-page-title-main">Ecolab</span> American corporation

Ecolab Inc. is an American corporation headquartered in Saint Paul, Minnesota. It develops and offers services, technology and systems that specialize in treatment, purification, cleaning and hygiene of water in a wide variety of applications. It helps organizations, both in private as well as public markets, treat their water for drinking use and for use in food, healthcare, hospitality-related safety and industry. Founded as Economics Laboratory in 1923 by Merritt J. Osborn, it was eventually renamed "Ecolab" in 1986.

<span class="mw-page-title-main">Alcon</span> Swiss-American pharmaceutical and medical device company

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Sigma Healthcare Limited is an Australian, ASX-listed company with a focus on the pharmacy industry. The company has pharmacy operations in retail, wholesale and distribution. From its head office in Clayton, Victoria, Sigma manages over 1,200 branded and independent pharmacies. Sigma Healthcare owns Australian retail pharmacy brands: Amcal, Discount Drug Stores and Guardian Pharmacy. The company also has a presence in the hospital pharmacy services, contract logistics, dose administration aids and other healthcare service adjacencies.

Synthes Holding AG is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, and also produces surgical power tools and advanced biomaterials.

<span class="mw-page-title-main">Rhön-Klinikum</span>

Rhön-Klinikum is a German cooperation of hospitals and clinics headquartered in Bad Neustadt an der Saale, Germany. It is a leading private hospital group in Germany.

<span class="mw-page-title-main">Bayer</span> German multinational pharmaceutical and biotechnology company

Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.

<span class="mw-page-title-main">Ulf Mark Schneider</span> German-American businessperson

Ulf Mark Schneider is a German-American businessman, and the CEO of Nestlé since 2017. He is the former CEO of the healthcare group Fresenius SE.

Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index (AScX). The head office of Fagron is located in Rotterdam.

<span class="mw-page-title-main">Khaled J. Saleh</span>

Khaled J. Saleh is a board-certified orthopaedic surgeon specializing in the diagnosis and treatment of orthopaedic conditions, and is known for surgery relating to adult reconstruction and joint replacement. Saleh's work has been supported by nearly $7 million in grant funding, resulting in over 200 scientific publications.

MDLinx is an internet-based service for physicians and healthcare professionals provided by M3 USA Corporation. It offers physicians and other healthcare professionals a means of staying current with academic literature. The typical medical specialist needs to read 30 to 80 journal articles every day to keep up with the flow of information in their specialty. MDLinx scans, sorts, summarizes, and disseminates new literature in a digestible form.

<span class="mw-page-title-main">Ebersburg Castle</span> Ruined hill castle in Ebersberg, East Hesse, Germany

Ebersburg Castle is a ruined hill castle in Ebersberg in the parish of Ebersburg in the county of Fulda in East Hesse, Germany. It is the symbol of Ebersberg as well as the origin of its name.

References

  1. 1 2 "Facts & Figures". bbraun.com. Archived from the original on 18 January 2016. Retrieved 20 January 2016.
  2. "B. Braun Sharing Expertise". www.bbraun.de. Retrieved 24 January 2020.
  3. "Group Management Report" (PDF). bbraun.com. Archived from the original (PDF) on 18 April 2016. Retrieved 20 January 2016.
  4. 1 2 Health Canada bans 'brain patch' linked to brain disease. CBC News, 15. April 2002.
  5. Dietz, Peter (4 March 2009). "Der Medizintechnik-Konzern B.Braun ist laut einer Studie bester Arbeitgeber der Republik (A study names the medical company B. Braun as the best employer in the Republic)". Frankfurter Rundschau. Retrieved 19 January 2013.
  6. bbraun.de: "Diabetes: B. Braun stellt den Vertrieb von Insulin ein". Archived from the original on 7 June 2012. Retrieved 16 September 2022.
  7. "Personalisierte Krebstherapie: B. Braun und CeGaT gründen Joint Venture CeCaVa". CeGaT GmbH (in German). 1 October 2018. Retrieved 18 August 2021.
  8. Ludwig Burger, Edward Taylor and Frank Siebelt (15 October 2013), B. Braun acquires blocking stake in Rhoen-Klinikum battle Reuters .
  9. Ludwig Burger and Frank Siebelt (11 October 2013), B. Braun cleared to raise stake in Rhoen-Klinikum Reuters .
  10. Ludwig Burger (10 May 2013), Rhoen says shareholder to challenge 90 pct acceptance hurdle Reuters .
  11. Ludwig Burger and Frank Siebelt (22 November 2012), Rhoen investor B. Braun fights hospitals deal in court Reuters .
  12. Ludwig Burger (18 November 2014), Rhoen on track to hand shareholders 1.63 bln euros via buy-back Reuters .
  13. 1 2 "Geschichte". www.bbraun.de (in German). Retrieved 19 August 2022.
  14. "B. Braun und Philips arbeiten gemeinsam an Innovationen auf dem Gebiet ultraschallgestützter Regionalanästhesie und vaskulärer Gefäßzugänge" (in German). Retrieved 18 August 2021.
  15. "Networking Expertise". bbraun.com. Archived from the original on 2 February 2013. Retrieved 12 February 2013.
  16. "B. Braun TransCare". B. Braun Melsungen website. Archived from the original on 11 May 2013. Retrieved 19 January 2013.
  17. "About Us". Archived from the original on 28 January 2014. Retrieved 1 February 2014.
  18. Corn, David (9 April 2015). "Mother Jones".
  19. "Aesculap, Inc. Company Profile". hoovers.com. Retrieved 12 February 2013.
  20. "Company Overview of Aesculap, Inc". Healthcare Equipment and Supplies. businessweek.com. Archived from the original on 13 October 2012. Retrieved 12 February 2013.
  21. "From Druggist To Global Player". Take the time for a short trip through more than 170 years of successful company and family history. bbraun.com. Archived from the original on 23 January 2013. Retrieved 12 February 2013.
  22. Bill Berkrot and James Vicini (7 December 2010), Abbott to pay $167 mln in settlements Reuters .